Skip to main content

The ZTALMY One™ Program

Marinus Pharmaceuticals

UnknownUnder review·Apr 24, 2026

The ZTALMY One™ Program is likely a patient support program offered by Marinus Pharmaceuticals for individuals prescribed ZTALMY (ganaxolone) for CDKL5 Deficiency Disorder. Without access to the page content, specific details regarding travel assistance coverage and eligibility are unknown, but it is implied to support patients using ZTALMY.

Enrollment cycle
unknown

Apply

Application goes directly to Marinus Pharmaceuticals. RxCopays does not receive compensation.

Go to application →

Status source

Without access to the page content, specific details regarding travel assistance coverage and eligibility are unknown

Rare-disease support beyond financial help

This grant covers a rare condition. For specialists, clinical trials, and patient communities, our sister site UniteRare.org has in-depth pages: